Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2020 08:00 ET | Source: OraSure Technologies, Inc.

OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples

BETHLEHEM, Pa., June 10, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and...
June 08, 2020 08:00 ET | Source: OraSure Technologies, Inc.

OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test

OTTAWA, June 08, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
June 03, 2020 20:50 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock

BETHLEHEM, Pa., June 03, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the full exercise by the underwriters of their option to...
June 02, 2020 23:15 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock

BETHLEHEM, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the pricing of an underwritten offering of 8,000,000 shares...
June 01, 2020 16:01 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock

BETHLEHEM, Pa., June 01, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced it has commenced an underwritten public offering of 8,000,000...
May 29, 2020 07:00 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.

BETHLEHEM, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and...
May 29, 2020 06:00 ET | Source: OraSure Technologies, Inc.

OraSure Technologies Appoints Lelio Marmora to Board of Directors

BETHLEHEM, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and...
May 26, 2020 06:00 ET | Source: OraSure Technologies, Inc.

OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference

BETHLEHEM, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and...
May 22, 2020 07:00 ET | Source: OraSure Technologies, Inc.

OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test

OTTAWA, May 22, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical...
May 22, 2020 06:00 ET | Source: OraSure Technologies, Inc.

Diversigen Inc. Selected by Nom Nom™ as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services

ST. PAUL, Minn. and OAKLAND, Calif., May 22, 2020 (GLOBE NEWSWIRE) -- Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), and Nom Nom™, a direct-to-consumer pet health brand,...